VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,101,000 | -94.1% | 117,902 | -77.3% | 0.02% | -94.5% |
| Q4 2015 | $52,802,000 | +395.0% | 519,444 | +768.6% | 0.29% | +681.1% |
| Q3 2015 | $10,667,000 | -41.9% | 59,800 | -53.4% | 0.04% | -26.0% |
| Q4 2014 | $18,346,000 | -57.2% | 128,200 | -60.7% | 0.05% | -59.3% |
| Q3 2014 | $42,824,000 | +164.9% | 326,400 | +154.6% | 0.12% | +156.2% |
| Q2 2014 | $16,168,000 | +142.5% | 128,200 | +125.7% | 0.05% | +166.7% |
| Q4 2013 | $6,668,000 | +12.5% | 56,800 | 0.0% | 0.02% | +12.5% |
| Q3 2013 | $5,926,000 | -63.7% | 56,800 | -70.0% | 0.02% | -68.6% |
| Q2 2013 | $16,315,000 | – | 189,530 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |